Global Pharmacovigilance Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2016 to 2022

  • ID: 4313240
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Accenture Plc.
  • Clinquest Group B.V.
  • F. Hoffmann-La Roche Ltd.
  • ICON plc
  • iMEDGlobal Corporation
  • PRA Health Sciences, Inc.
  • MORE

The pharmacovigilance market was valued at USD 2,159.3 Mn in 2015, and is expected to reach USD 5,896.4 Mn by 2022, expanding at a CAGR of 15.8% from 2016 to 2022.

Market Insights
Increasing demands on pharmaceutical manufacturers and other intermediaries regarding early identification of drug adversities, growing concerns over drug safety and growing need for prompt compliance to regulatory guidelines have led to emergence of pharmacovigilance services. Moreover, withdrawals of several high profile drugs in the past have urged pharmaceutical manufacturers to closely observe GPvP practices to preserve their stronghold in the market.
Among the phases of drug development namely, preclinical studies, phase I, phase II, phase III, phase IV or post marketing surveillance, phase IV segment is the largest revenue generating segment in the pharmacovigilance market. Standing at above 55% market share in 2015, as this stage is highly instrumental in assessing drug safety in the widest range of patients and registers the highest number of events. Phase IV assessment is also highly instrumental in product life cycle management of high profile drugs. In addition, phase III stage pharmacovigilance enables convenient and robust commercialization of novel drugs thus ensuring strong future foothold in the market.

Spontaneous reporting, intensified ADR reporting, targeted spontaneous reporting, cohort event monitoring, and EHR mining are the major methods of pharmacovigilance reporting. Our analysis estimates spontaneous reporting to be the largest segment in 2015 and is expected to maintain its dominance during the through the forecast period. Efficient identification of adverse effects that were previously unknown and less expensive processing are the major contributors to the market growth of this segment.

Pharmacovigilance is conducted either in-house or through contract outsourcing. Between the two options, the later method is the most widely adopted by both large and mid-sized pharmaceutical companies. The trend of adopting in-house pharmaceutical is thus expected to be low in the future due to growing preference of pharmaceutical manufacturers towards cost containment of operations and their growing focus on developing core competencies.

Geographically, North America and Europe take over half the pharmacovigilance market. Asia-Pacific, on the other hand, is anticipated to be the fastest growing regional market for pharmacovigilance due to growing awareness in the emerging economies, and government initiatives regarding drug safety. This market is observed to be highly fragmented with several BPOs and CROs currently operational in the international markets. PAREXEL International, Covance, Quintiles, Accenture, Cognizant Technology Solutions are some of the notable names in this market.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Accenture Plc.
  • Clinquest Group B.V.
  • F. Hoffmann-La Roche Ltd.
  • ICON plc
  • iMEDGlobal Corporation
  • PRA Health Sciences, Inc.
  • MORE
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Pharmacovigilance Market Share, by Drug Development Phase, 2015 (Value %)
2.2 Pharmacovigilance Market, by Methods, 2014-2022 (USD Mn)
2.3 Pharmacovigilance Market, by Services, 2014-2022 (USD Mn)
2.4 Pharmacovigilance Market Share, by Geography, 2015 (Value %)

Chapter 3 Pharmacovigilance Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Attractive Investment Proposition
3.1 Competitive Analysis: Fractal Map Investigation, by Key Market Players

Chapter 4 Global Pharmacovigilance Market Analysis, by Drug Development Phase
4.1 Preface
4.2 Preclinical Studies
4.3 Phase I
4.4 Phase II
4.5 Phase III
4.6 Phase IV or Post Marketing Surveillance

Chapter 5 Global Pharmacovigilance Market Analysis, by Reporting Methods
5.1 Preface
5.2 Spontaneous Reporting
5.3 Intensified Adr Reporting
5.4 Targeted Spontaneous Reporting
5.5 Cohort Event Monitoring
5.6 Ehr Mining

Chapter 6 Global Pharmacovigilance Market Analysis, by Services
6.1 Preface
6.2 Chemotherapy
6.3 Contract Outsourcing

Chapter 7 Global Pharmacovigilance Market, by Geography
7.1 Preface
7.2 North America
7.3 Europe
7.4 Asia-Pacific
7.5 Middle East and Africa (Mea)
7.6 Latin America

Chapter 8 Company Profiles
8.1 Accenture Plc
8.1.1 Business Description
8.1.2 Financial Health and Budget Allocation
8.1.3 Product Positions/Portfolio
8.1.4 News Coverage
8.2 Bristol-Myers Squibb
8.2.1 Business Description
8.2.2 Financial Health and Budget Allocation
8.2.3 Product Positions/Portfolio
8.2.4 News Coverage
8.3 Clinquest Group B.V
8.3.1 Business Description
8.3.2 Financial Health and Budget Allocation
8.3.3 Product Positions/Portfolio
8.3.4 News Coverage
8.4 Cognizant Technology Solutions
8.4.1 Business Description
8.4.2 Financial Health and Budget Allocation
8.4.3 Product Positions/Portfolio
8.4.4 News Coverage
8.5 Covance, Inc
8.5.1 Business Description
8.5.2 Financial Health and Budget Allocation
8.5.3 Product Positions/Portfolio
8.5.4 News Coverage
8.6 F. Hoffmann-La Roche Ltd
8.6.1 Business Description
8.6.2 Financial Health and Budget Allocation
8.6.3 Product Positions/Portfolio
8.6.4 News Coverage
8.7 Gsk
8.7.1 Business Description
8.7.2 Financial Health and Budget Allocation
8.7.3 Product Positions/Portfolio
8.7.4 News Coverage
8.8 Icon Plc
8.8.1 Business Description
8.8.2 Financial Health and Budget Allocation
8.8.3 Product Positions/Portfolio
8.8.4 News Coverage
8.9 Igate Corporation
8.9.1 Business Description
8.9.2 Financial Health and Budget Allocation
8.9.3 Product Positions/Portfolio
8.9.4 News Coverage
8.10 Imedglobal Corporation
8.10.1 Business Description
8.10.2 Financial Health and Budget Allocation
8.10.3 Product Positions/Portfolio
8.10.4 News Coverage
8.11 Inventiv Health, Inc
8.11.1 Business Description
8.11.2 Financial Health and Budget Allocation
8.11.3 Product Positions/Portfolio
8.11.4 News Coverage
8.12 Parexel International Corporation
8.12.1 Business Description
8.12.2 Financial Health and Budget Allocation
8.12.3 Product Positions/Portfolio
8.12.4 News Coverage
8.13 Pra Health Sciences, Inc
8.13.1 Business Description
8.13.2 Financial Health and Budget Allocation
8.13.3 Product Positions/Portfolio
8.13.4 News Coverage
8.14 Quintiles Transnational Holdings, Inc
8.14.1 Business Description
8.14.2 Financial Health and Budget Allocation
8.14.3 Product Positions/Portfolio
8.14.4 News Coverage
8.15 Synowledge Llc
8.15.1 Business Description
8.15.2 Financial Health and Budget Allocation
8.15.3 Product Positions/Portfolio
8.15.4 News Coverage
8.16 Wipro Limited
8.16.1 Business Description
8.16.2 Financial Health and Budget Allocation
8.16.3 Product Positions/Portfolio
8.16.4 News Coverage
8.17 Others

List of Figures
Figure 1 Pharmacovigilance: Market Segmentation
Figure 2 Pharmacovigilance Market Share, by Drug Development Phase, 2015 (Value %)
Figure 3 Pharmacovigilance Market, by Methods, 2014-2022 (USD Mn)
Figure 4 Pharmacovigilance Market, by Services, 2014-2022 (USD Mn)
Figure 5 Pharmacovigilance Market Share, by Geography, 2015 (Value %)
Figure 6 Attractive Investment Proposition, Pharmacovigilance Market, 2015
Figure 7 Competitive Analysis: Fractal Map Investigation, by Key Market Players
Figure 8 Global Preclinical Studies Market, 2014 - 2022 (USD Mn)
Figure 9 Global Phase I Pharmacovigilance Market, 2014 - 2022 (USD Mn)
Figure 10 Global Phase I Pharmacovigilance Market, 2014 - 2022 (USD Mn)
Figure 11 Global Phase III Pharmacovigilance Market, 2014 - 2022 (USD Mn)
Figure 12 Global Phase IV or Post Marketing Surveillance Pharmacovigilance Market, 2014 - 2022 (USD Mn)
Figure 13 Global Spontaneous Reporting Market, 2014 - 2022 (USD Mn)
Figure 14 Global Intensified Adr Reporting Market, 2014 - 2022 (USD Mn)
Figure 15 Global Targeted Spontaneous Reporting Market, 2014 - 2022 (USD Mn)
Figure 16 Global Cohort Event Monitoring Market, 2014 - 2022 (USD Mn)
Figure 17 Global Ehr Mining Market, 2014 - 2022 (USD Mn)
Figure 18 Global In-House Pharmacovigilance Market, 2014 - 2022 (USD Mn)
Figure 19 Global Contract Outsourcing Pharmacovigilance Market, 2014 - 2022 (USD Mn)
Figure 20 U.S. Pharmacovigilance Market, 2014 - 2022 (USD Mn)
Figure 21 Canada Pharmacovigilance Market, 2014 - 2022 (USD Mn)
Figure 22 U.K. Pharmacovigilance Market, 2014 - 2022 (USD Mn)
Figure 23 Germany Pharmacovigilance Market, 2014 - 2022 (USD Mn)
Figure 24 Rest of Europe Pharmacovigilance Market, 2014 - 2022 (USD Mn)
Figure 25 Japan Pharmacovigilance Market, 2014 - 2022 (USD Mn)
Figure 26 China Pharmacovigilance Market, 2014 - 2022 (USD Mn)
Figure 27 Rest of Asia-Pacific Pharmacovigilance Market, 2014 - 2022 (USD Mn)
Figure 28 Middle East and Africa Pharmacovigilance Market, 2014 - 2022 (USD Mn)
Figure 29 Latin America Pharmacovigilance Market, 2014 - 2022 (USD Mn)

List of Tables
Table 1 Global Pharmacovigilance Market, by Drug Development Phase, 2014 - 2022 (USD Mn)
Table 2 Global Pharmacovigilance Market, by Reporting Methods, 2014 - 2022 (USD Mn)
Table 3 Global Pharmacovigilance Market, by Services, 2014 - 2022 (USD Mn)
Table 4 Global Pharmacovigilance Market, by Geography, 2014 - 2022 (USD Mn)
Table 5 North Pharmacovigilance Market, by Country, 2014 - 2022 (USD Mn)
Table 6 Europe Pharmacovigilance Market, by Country, 2014 - 2022 (USD Mn)
Table 7 Asia-Pacific Pharmacovigilance Market, by Country, 2014 - 2022 (USD Mn)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Accenture Plc.
  • Bristol-Myers Squibb
  • Clinquest Group B.V.
  • Cognizant Technology Solutions
  • Covance, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GSK
  • ICON plc
  • iGATE Corporation
  • iMEDGlobal Corporation
  • inVentiv Health, Inc.
  • PAREXEL International Corporation
  • PRA Health Sciences, Inc.
  • Quintiles Transnational Holdings, Inc.
  • Synowledge LLC
  • Wipro Limited
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll